One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood.v130.suppl_1.817.817
Copy DOI Journal: Blood |  Publication Date: Dec 7, 2017 |
 Citations: 13 |
Affiliation: Moffitt Cancer Center, UCLA Medical Center, Memorial Sloan Kettering Cancer Center, Hamamatsu University School of Medicine, Huntsman Cancer Institute, Dana-Farber Cancer Institute, University of Alabama at Birmingham, Leiden University, Lymphoma Research Foundation, St Thomas' Hospital, University of Turin, NIHR Surgical Reconstruction and Microbiology Research Centre, Peter MacCallum Cancer Centre, University Hospital Münster, Clinical Solutions, Vanderbilt University Medical Center, University of Pennsylvania, Tokyo National Hospital, University of Bologna, Stanford University, Research Institute Hospital 12 de Octubre, Thomas Jefferson University, Hospices Civils de Lyon, Claude Bernard University Lyon 1, The University of Texas MD Anderson Cancer Center, UC Irvine Health, Inserm, Université Paris Cité, Hôpital Saint-LouisAnti-CCR4 Monoclonal Antibody, Mogamulizumab, Demonstrates Significant Improvement in PFS Compared to Vorinostat in Patients with Previously Treated Cutaneous T-Cell Lymphoma (CTCL): Results from the Phase III MAVORIC Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
